Loading...

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results

BACKGROUND: Capecitabine, an orally administered fluoropyrimidines, is widely used in the treatment of multiple malignancies. It has been extensively evaluated in patients with gastroesophageal carcinoma. Since recent reviews have discussed phase I/II trials (Cancer 107:221–231, 2006; Drugs 67:601–6...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Cen, Putao, Tetzlaff, Eric D, Ajani, Jaffer A
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2008
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2503649/
https://ncbi.nlm.nih.gov/pubmed/18728703
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!